Pioglitazone (Gluconorm -P 30) is a thiazolidinedione antidiabetic, prescribed for type 2 diabetes in certain patients. It is used along with diet and exercise. It may be used alone or with other ...

Nonalcoholic steatohepatitis (NASH) is an increasingly common cause of chronic liver disease worldwide. Currently, no specific pharmacologic therapy has been shown to treat NASH effectively. Because ...

Pioglitazone is a generic prescription medication. The Food and Drug Administration (FDA) has approved it to help manage blood sugar levels in adults with type 2 diabetes. It’s meant to be used ...

No pharmacologic therapy has conclusively proved to be effective for the treatment of nonalcoholic steatohepatitis, which is characterized by insulin resistance, steatosis, and necroinflammation with ...

Nonalcoholic steatohepatitis is a common liver disease that can progress to cirrhosis. Currently, there is no established treatment for this disease. We randomly assigned 247 adults with nonalcoholic ...

Objective: Hepatic triglyceride is closely associated with hepatic insulin resistance and is known to be decreased by thiazolididinediones. We studied the effect of pioglitazone on hepatic ...

Actos (pioglitazone) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as an oral tablet that’s taken once per day. Actos is used to help manage blood sugar levels in adults ...

In a new, proof-of-concept study, pioglitazone has been shown to lessen the metabolic and histologic abnormalities associated with nonalcoholic steatohepatitis (NASH), for which there is currently no ...

BOSTON, April 30, 2004 – Results of three studies show the oral anti-diabetic agent ACTOS (R) (pioglitazone HCl), in combination with a sulfonylurea, metformin or insulin, resulted in triglyceride ...

Women with polycystic ovary syndrome (PCOS) tend to be overweight and insulin-resistant, but pioglitazone treatment improves their insulin sensitivity, and leads to improved ovulatory function. High ...

The pioglitazone safety warning issued in South Korea, which recommended prescribing with careful attention among those with high risk of bladder cancer, led to a moderate decrease in pioglitazone ...

Pioglitazone (Matce -P 30) is a thiazolidinedione antidiabetic, prescribed for type 2 diabetes in certain patients. It is used along with diet and exercise. It may be used alone or with other ...